Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2021

May 14, 2021

SELL
$109.18 - $185.98 $26.3 Million - $44.8 Million
-241,000 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$65.74 - $169.86 $9.01 Million - $23.3 Million
137,000 Added 131.73%
241,000 $25.2 Million
Q2 2020

Aug 12, 2020

BUY
$29.67 - $80.0 $3.09 Million - $8.32 Million
104,000 New
104,000 $6.68 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $16.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Anson Funds Management LP Portfolio

Follow Anson Funds Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Anson Funds Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Anson Funds Management LP with notifications on news.